Publication | Open Access
Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
44
Citations
13
References
2011
Year
Insulin secretion evaluated by F-CPR, CPI, I.I., U-CPR and the duration of type 2 diabetes were useful parameters for predicting the efficacy of liraglutide in patients with type 2 diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00168.x, 2011).
| Year | Citations | |
|---|---|---|
Page 1
Page 1